Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

Glucuronolactone Global Market Report 2022: Increasing Demand for Energy Drinks and Supplements Bolsters Sector

Research and Markets Logo

News provided by

Research and Markets

Mar 30, 2023, 22:00 ET

Share this article

Share toX

Share this article

Share toX

DUBLIN, March 30, 2023 /PRNewswire/ -- The "Glucuronolactone Market By Type, By Application, By End-use, and By Region Forecast to 2030" report has been added to  ResearchAndMarkets.com's offering.


The global market size for glucuronolactone was USD 350.1 million in 2021 and is anticipated to experience a compound annual growth rate (CAGR) of 5.9% during the forecast period.

The growth of the market can be attributed to various factors such as the changing lifestyles, increasing awareness among consumers regarding health and fitness due to the penetration of the internet, and the growing use of glucuronolactone as a detoxifying agent in functional beverages.

Glucuronolactone is a chemical that is primarily utilized in the production of energy drinks to enhance attention and athletic performance. It is a naturally occurring substance present in small amounts in nearly all connective tissues produced by the body. Additionally, it can be synthesized in laboratories for use in food and beverages as a performance enhancer and recovery aid.

The healthcare and pharmaceutical industries are expected to be major drivers of revenue growth for the market due to the widespread use of glucuronolactone in joint treatment to improve muscle function and mental health. This solid and white substance occurs naturally and has multiple physical and mental benefits, which have drawn the attention of the medical industry.

Furthermore, increasing health awareness due to the penetration of the internet and changing lifestyles is expected to drive market revenue growth. Glucuronolactone functions as a detoxicant, aiding in the removal of harmful substances from body cells. It is essential for healing joints and torn muscles after strains as it is a component of the body's connective tissues. Additionally, it is vital for the synthesis of Vitamin C, which enhances immunity and increases bodily resistance generally.

However, the lack of glucuronolactone in the human body can lead to a wide range of diseases such as cardiovascular disease, epilepsy, and retinal degeneration. Therefore, the rising awareness of a healthy lifestyle and glucuronolactone deficiency is causing a high demand for this product, driving market revenue growth.

Market Dynamics
Drivers:

Increasing Demand for Energy Drinks and Supplements

Glucuronolactone is a widely used ingredient in various energy drinks and supplements due to its numerous benefits. It is added to energy drinks because when combined with caffeine and taurine, it can increase energy levels and alertness. In addition, glucuronolactone is utilized as a supplement to improve alertness, prevent mental fatigue, and support joint and tendon health. According to studies, taking a pre-workout energy supplement containing glucuronolactone, caffeine, taurine, beta-alanine, creatine, and amino acids 10 minutes before resistance exercises resulted in a significant improvement in workout performance.

Restraint:

Awareness of Glucuronolactone Side Effects

Glucuronolactone-based products may have side effects such as anxiety, insomnia, muscle twitching, and an increased heart rate, which could be harmful to individuals with high blood pressure. Research suggests that a safe dose for glucuronolactone supplementation is between 500 to 600 mg per day. However, when taken in high doses, it can cause various side effects, including headaches, stomach cramps, and irritation. Furthermore, high doses of glucuronolactone have been linked to aggressive behavior and insomnia, which could hinder market growth.

Application Insights

The global glucuronolactone market is segmented by application into preservatives, antioxidants, energy supplements, processing aids and additives, and others. In 2021, the antioxidants segment had the largest revenue share. Glucuronolactone is known to protect the liver by improving glucuronidation detoxification pathway, reducing liver tissue damage and inflammation, and boosting the activity of antioxidant liver enzymes. It also helps in detoxifying the body from harmful chemicals, hormones, and pollutants, driving the revenue growth of this segment.

End-use Insights

The global glucuronolactone market is segmented by end-use into dietary supplements, energy drinks, pharmaceuticals, cosmetics, and functional food. The dietary supplements segment had the largest revenue share in 2021. Supplements containing glucuronolactone help in weight training and bodybuilding, enabling athletes to work out longer and more intensely, leading to improvements in physical performance, strength, muscular mass, and body composition. The energy drink segment is expected to have a steady revenue growth rate during the forecast period, as glucuronolactone is known to increase energy levels when mixed with other ingredients such as taurine and caffeine. Glucuronolactone also helps to enhance aerobic and anaerobic performance, driving the revenue growth of this segment.

Regional Insights

Based on regional analysis, the North America market had the largest revenue share in 2021, due to the increasing desire for a healthy lifestyle and the rising demand for healthy energy drinks and supplements, particularly for patients suffering from lifestyle disorders such as diabetes, obesity, and cardiovascular diseases. The Asia Pacific market is expected to register a fast growth rate during the forecast period, due to rising investments and development of energy drink companies using glucuronolactone as their key ingredient. The Europe market is expected to have a steady revenue growth rate during the forecast period, with rising innovation by key companies, such as Coca-Cola's development of its first energy drink under the Coca-Cola brand in the UK, using glucuronolactone to compete with Red Bull, Lucozade, and Monster.

Competitive Landscape

The global glucuronolactone market has a consolidated competitive landscape, with only a few key players operating on both global and regional levels. These players are focused on developing new products and forming strategic alliances to expand their product portfolios and gain a strong position in the global market. Some of the major players in the market are Hubei Yitai Pharmaceutical Co., Ltd., Shaoxing Marina Biotechnology Co., Ltd, Merck KGaA, Foodchem International Corporation, Anhui Fubore Pharmaceutical and Chemical Co., Ltd., Jungbunzlauer Suisse AG, Roquette Freres, Shandong Fuyang Bio-Tech CO.LTD., Actylis, Suzhou Fifth Pharmaceutical Factory Co.

Market players are driving market growth by taking initiatives. For instance, on 2 August 2022, PepsiCo invested USD 550 million in the functional energy drink Celsius as part of its strategy to focus on the energy category and leverage an opportunity to jointly promote industry development and innovation. A long-term strategic distribution partnership was also formed between the two companies, with PepsiCo taking over US distribution and becoming the preferred partner internationally.

Companies Mentioned

  • Hubei Yitai Pharmaceutical Co. Ltd.
  • Shaoxing Marina Biotechnology Co.
  • Ltd
  • Merck KGaA
  • Foodchem International Corporation
  • Foodchem International Corporation
  • Anhui Fubore Pharmaceutical and Chemical Co. Ltd.
  • Jungbunzlauer Suisse AG
  • Roquette Freres
  • Shandong Fuyang Bio-Tech CO.LTD.
  • Actylis
  • Suzhou Fifth Pharmaceutical Factory Co.

For more information about this report visit https://www.researchandmarkets.com/r/1egv47

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]
 
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
 
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

SOURCE Research and Markets

21%

more press release views with 
Request a Demo

Modal title

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2026 Cision US Inc.